Correction: Alpinetin pretreatment prevents lipopolysaccharide/D-galactosamine-induced acute liver injury in mice by inhibiting ferroptosis via the Nrf2/SLC7A11/GPX4 pathway

The original version of this Article contained errors in Figure 3. Due to an error during preparation of this figure, the H&E image for Alpinetin+LPS/D-GalN (12.5 mg/kg) in panel A (bottom left) was derived from the same original image as the H&E image for Alpinetin+LPS/D-GalN (50 mg/kg) in panel A (bottom right). The original Figure 3 and accompanying legend appear below. Fig. 3 Effect of alpinetin in mice with LPS/D-GalN-induced ALI. ( A ) Histopathological sections of the liver (Original magnification, 200 ×, scale bar, 100 μm). ( B ) Liver histopathologic score. ( C ) Liver index (%). All data are presented as the mean ± SEM. P ### < 0.001 vs. control group; P* < 0.05, P** < 0.01 and P*** < 0.001 vs. LPS/D-GalN group. Full size image